Serum contains many growth factors and nutrients that stimulate colony formation of hematopoietic progenitor cells (HPC) in semisolid cultures, In the absence of serum, no proliferation of HPCs could be obtained in semisolid medium cultures of partially purified bone marrow cells in the presence of multiple hematopoietic growth factors, insulin, cholesterol, and purified clinical-grade human albumin. This appeared to be due to a suppressive activity induced by monocyte-and T lymphocyte-depleted accessory cells on CD34 + HPCs. Serum-free conditioned medium from the bladder carcinoma cellline 5637 could replace serum to support the growth of HPCs in these cultures. After gel filtration and reverse-phase high-performance liquid chromatography of 5637 supernatants, this activity could be attributed to a 15-kD protein that was further identified by NH2-terminal sequence analysis as the serine proteinase inhibitor antileukoproteinase (ALP). The growth-supportive activity from the 5637 conditioned medium and the (partially) purified fractions could be completely neutralized by a polyclonal rabbit IgG antibody against human ALP (huALP). Similar supportive effects on the growth of HPC could be obtained in the presence of recombinant huALP. We demonstrated that the COOH-terminal domain of ALP containing the proteinase inhibitory activity was responsible for this effect, o~-1 proteinase inhibitor was capable of similar support of in vitro HPC growth. These results illustrate that proteinase inhibitors play an important role in the in vitro growth of hematopoietic ceils by the neutralization of proteinases produced by bone marrow accessory cells. This may be of particular relevance for in vitro expansion of human hematopoietic stem cells in serum-free media.
C
haracterization of hematopoiesis in humans is dependent on the in vitro analysis of hematopoietic progenitor cells (HPC) 1. HPCs can be studied using semisolid medium cultures, and their potential for proliferation and differentiation can be characterized by their ability to form IAbbreviations used in this paper: oe-1 PI, or-1 proteinase inhibitor; ALP, antileukoproteinase; bFGF, basic fibroblast growth factor; BFU-E, burstforming unit erythroid colony; CM, conditioned medium; CPG, controlled pore glass; EGF, epidermal growth factor; EPO, erythropoietin; GCSF, granulocyte colony stimulating factor; GM, granulocyte macrophage; HGF, hematopoietic growth factor; HPC, hematopoietic progenitor cell; HSA, human serum albumin; huALP, human antileukoproteinase; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor; rALP, recombinant human antileukoproteinase; RP-HPLC, reverse-phase HPLC; SCF, stem cell factor; TFA, trifluroacetic acid.
colonies of hematopoietic cells in these cultures. The growth and differentiation of HPC in colony assays depend on the presence of hematopoietic growth factors (HGF) in the cultures (1) . These HGF may be added to the culture medium or produced by accessory cells or HPC as paracrine or autocrine growth factors, respectively. In addition, factors that are present in serum, including insulin, cholesterol, or albumin, are critical for the in vitro growth of HPC (2) (3) (4) (5) (6) (7) . BSA, frequently used as a source of albumin, is usually not >95-99% pure because of its strong proteinbinding properties (8, 9) . Since in serum-free colony assays, BSA is often used at relatively high concentrations, residual undefined proteins may significantly contribute to the growth-supportive potential of BSA. Pilot studies in our laboratory indicated that in contrast to these BSA preparations, highly purified concentrates of clinical-grade human albumin did not support the proliferation of HPC from monocyte-and T lymphocyte-depleted mononuclear bone marrow cells in semisolid medium cultures in the presence of HGF, cholesterol, and insulin. In this study, we analyzed the mechanisms of this finding and showed that this was due to a suppressive effect of monocyte-and T lymphocyte-depleted bone marrow accessory cells on CD34-purifled HPC. We investigated which serum factor, in addition to human albumin, insulin, and cholesterol, was responsible for supporting the in vitro proliferation of bone marrowderived HPC. We found that a 15-kD protein present in conditioned medium (CM) from the bladder carcinoma cell line 5637 could replace serum. This protein was identified as the serine proteinase inhibitor antileukoproteinase (ALP).
Materials and Methods
Cell Preparations. After informed consent, bone marrow samples were obtained from healthy donors. The cells were centrifuged on Ficoll Isopaque (density 1.077 g/cm 3, 20 min, 1,000 g), and mononuclear cells were depleted of monocytes and T lymphocytes as described previously (10) . These enriched bone marrow samples were cryopreserved and stored in liquid nitrogen. hnmediately before use, the cells were thawed rapidly in a water bath of 37~ washed once in cold (0~ RPMI-1640 medium (Hyclone Labs., Logan, UT) supplemented with 20% (vol/vol) fetal bovine serum (Boehringer, Mannheim, Germany), and twice with cold RPMI-1640 medium supplemented with 0.1% (wt/vol) clinical grade human serum albumin (HSA; Central Laboratory of the Bloodtransfusion Services, Amsterdam, The Netherlands). The cells were resuspended in IMDM (Hyclone Labs.) supplemented with 0.1% (wt/vol) HSA. In some experiments, highly purified CD34 + cells were isolated from the monocyteand T lymphocyte-depleted bone marrow cells. The CD34 + cells were either selected after staining with FITC-conjugated CD34-specific mAbs (HPCA-2; Becton Dickinson, Mountain View, CA) and sorted with a FACStar | PLUS (Becton Dickinson) or isolated after incubation with magnetic Dynabeads M-450 (Dynal Inc., Lake Success, NY) coated with a primary antibody specific for the CD34 Ag. After magnetizing the CD34 + cells, the nonbinding population was harvested as the CD34 accessory cells. The CD34 + cells were recovered after incubation with a sheep polyclonal antibody anti-CD34 Fab IgG (Detachabead CD34; Dynal Inc.), resulting in >80% pure CD34 + cells.
Cytokines and Antibodies. All cytokines used in this study were recombinant human proteins and used at plateau concentration to induce optimal colony growth. The cytokines and final concentrations used were: stem cell factor (SCF) (50 ng/ml), granulocyte-colony stinmlating factor (G-CSF) (10 ng/ml), basic fibroblast growth factor (bFGF) (10 ng/ml), and epidermal growth factor (EGF) (10 ng/ml) provided by Amgen (Thousand Oaks, CA); IL-3 (50 ng/ml), IL-11 (10 ng/ml), monocyte-CSF (1,000 U/ml), and GM-CSF (10 ng/ml) were provided by Genetics Institute (Cambridge, MA); IL-lc~ (10 ng/ml), IL-5 (10 ng/ml), and IL-12 (10 ng/ml) were gifts from Hoffman La Roche (Nutley, NJ); IL-4 (500 U/ml) and IL-7 (10 ng/ml) were gifts from hnmunex Corporation (Seattle, WA); IL-6 (1 ng/ml) and IL-8 (10 ng/ml) were gifts from Sandoz (Basel, Switzerland); plateletderived growth factor (PDGF; 30 ng/ml) was obtained from GIBCO BRL (Gaithersburg, MD); insulin-like growth factors (IGF-I, IGF-II, 250 ng/ml) were obtained from Genzyme Corporation (Cambridge, MA); and erythropoietin (EPO) (1 1U/ml) was a gift from Cilag (Herentals, Belgium). IL-9 (1,000 U/ml) was provided by Ludwig Institute for Cancer, (Brussels, Belgium), IL-10 (10 ng/ml) was obtained from Schering-Plough Research Institute (Kenilworth, NJ), and IL-2 (300 U/ml) was a gift from Roussel Uclaf (Paris, France Freiburg, Germany) at a final concentration of 1.l% (wt/vol) and a mixture of cytokines: GM-CSF (10 ng/ml), G-CSF (10 ng/ml), IL-3 (50 ng/ml), SCF (50 ng/ml), and EPO (1 IU/ml). All cytokines were present at saturating concentrations. This culture medium was supplemented either with control medium, hunran AB serum from healthy blood donors (10% [vol/vol]) that was prescreened for alloantibodies and inactivated for 30 rain at 56~ or a CM produced by the human bladder carcinoma cell line 5637 in the absence of serum, or (partially) purified fractions from this CM or proteinase inhibitors. Purified CD34 + cells were cultured in the absence or presence of increasing numbers ofmonocyte-and T lymphocyte-depleted bone marrow accessory cells.
In some experiments, to neutralize the biologic activity of these supplements, a 2-h incubation at 37~ and 5% CO2 in the presence of neutralizing concentrations ofanti-huALP antibodies was performed before initiation of the bone marrow culture. After 12 d of incubation in a fully humified atmosphere of 5% CO 2 at 37~ colonies were counted. Granulocyte-macrophage colony-forming units (CFU-GM) were defined as aggregates of at least 50 cells and burst-forming unit erythroid colonies (BFU-E) as henmglobinized bursts. To calculate the HPC growth in the partially purified bone marrow fractions, the colony growth induced by the culture medium alone was considered background and therefore in these experiments subtracted from the colony growth induced by AB serum, CM, or purified CM fraction. BFU-E and CFU-GM growth in the presence of 10% (vol/vol) AB serum was considered 100% growth (control culture). Colony growth was expressed as percentage growth of the control culture. human transferrin, saturated with FeCIO 3 9 6H20. After 48 h, the culture supematant was harvested. The crude supernatant was centrifuged (15 rain, 500 g, 20~ irradiated (50 Gy), and frozen at -20~ after addition of 0.1% (wt/vol) HSA for stabilization.
Production of CM.

Purification of CM.
Crude supernatant from 5637 cells was incubated for 2 h at 4~ with controlled pore glass (CPG) beads (PG-350-200; Sigma) for adsorbtion at pH 7.0 (14-16). The CPG beads were washed with Dulbecco's modified PBS and 0.01 M glycine/HC1, pH 3.5. The protein fraction was eluted by carefully stirring with 0.3 M glycine/HC1, pH 2.0 (1/10 of original crude volume), concentrated and neutralized by dialysis against PBS containing 10% (wt/vol) polyethylene glycol (PEG 20.000) (Serva, Heidelberg, Germany). For further fractionation of proteins, a gel filtration was performed on Ultrogel ACA 54 (Pharmacia, Uppsala, Sweden) by using a 2.6 • 100-cm column and a flow rate of 22 ml/h. BSA (Mr 67,000), OVA (M r 45,000), chymotrypsinogen (M r 25,000), and lysozyme (M r 14,300) were used as molecular mass markers. 5.5-ml fractions were collected by elution with 18% ethylene glycol buffer in 1.55 M NaCI, 8 mM phosphate, pH 7.2. The protein concentration was analyzed by a Coomassie blue/G-250 binding assay, using the Bio-Rad (Richmond, CA) commercial kit and BSA as a standard. Fractions from the Ultrogel column that could support colony growth of HPC were supplemented with Tween 20 (0.01% vol/vol), concentrated on a centricon-3 filter (Amicon Inc., Beverly, MA), and further fractionated by reverse-phase HPLC (P,P-HPLC). The concentrate was injected on a C8-Aquapore ILP-300 (2.1 • 220 ram) column (Applied Biosystems Inc., Foster City, CA) and equilibrated with 0.1% trifluoroacetic acid (TFA). Proteins were eluted at a flow rate of 0.4 ml/nfin with a linear gradient of acetonitrile (0-80% in 80 min) in 0.1% TFA. 400-p~l fractions were collected in tubes containing 0.01% (final concentration) Tween 20, and the absorption at 220 nm was measured.
Active P-,P-HPLC fractions, containing low protein concentrations, were analyzed for purity by SDS-PAGE. Samples (20 p,1) were loaded onto a polyacrylamide gel (reducing conditions), run simultaneously with molecular mass markers, and proteins were silver stained. The electrophoretically pure fractions were finally analyzed on a 477A protein sequencer with on-line detection of the phenylthiohydantoin AA in a 120A analyzer (Applied Biosysterns) (17). Chemical digestion of protein was obtained with 75% formic acid at 37~ for 50 h (17).
Results
Influence of Serum and Accessory Cells on HPC Growth.
In cultures containing 10% AB serum and HGF (IL-3, GM-CSF, G-CSF, SCF, EPO), the absolute numbers of HPC per 103 monocyte-and T lymphocyte--depleted bone marrow cells were 21 + 2 CFU-GM and 20 + 2 BFU-E (, = 8).
Replacement of AB serum by HSA (0.6% wt/vol), cholesterol (20 p~g/ml), and insulin (10 ~g/ml) resulted in only 4 _+ 1 GM colonies and no BFU-E growth per 103 monocyte-and T lymphocyte-depleted mononuclear bone marrow cells plated (background colony growth). In contrast, in cultures of purified CD34 + cells, HPC growth in the presence of 10% AB serum yielded 16 ---1 CFU-GM and 10 +-1 BFU-E per 150 cells plated, whereas in the absence of AB serum, 9 + 2 CFU-GM and 6 -+ 1 BFU-E were cultured (n = 10). Fig. 1 shows that addition of monocyteand T lymphocyte-depleted CD34-bone marrow cells to purified CD34 + ceils resulted in a dose-dependent inhibition of HPC growth in the absence, but not in the presence of AB serum, illustrating that serum contains factors capable of supporting HPC growth in the presence of bone marrow accessory cells. All cultures were perfomled in the presence of optimal concentrations ofHGF (GM-CSF 10 ng/ml, G-CSF 10 ng/ml, IL-3 50 ng/ml, SCF 50 ng/ml, and EPO 1 IU/ml). rophage CSF, in addition to the cytokines present in the culture medium, did not result in additive growth of colonies from monocyte-and T lymphocyte-depleted bone marrow cells (data not shown). However, addition of 3 -10% (vol/vol) CM, produced by 5637 cells in the absence of serum, could support the colony growth up to levels similar to the growth observed in the presence of 10% AB serum. Replacement of AB serum by 10% (vol/vol) 5637 C M to the culture medium supported 136 + 12% of C F U -G M growth and 85 + 4% of BFU-E growth as compared to the control culture. These results show that in the presence of purified hulnan albumin, 5637 cells produce factors that can support the growth of C F U -G M and BFU-E comparable to the effect of AB serum ( Table 1) .
Influence of 5637 CM on HPC Growth in the
Characterization of the Supportive Factor from 5637 CM.
The protein fraction from the 5637 CM, concentrated by adsorption to and elution froln the CPG beads, contained the colony growth supportive Factor with a fivefold higher concentration of activity compared to the crude 5637 supernatant (data not shown). After gel filtration of the C P G - eluate into 90 fractions, the major protein peaks were recovered from fractions 30 to 40 (>45 kD). As illustrated in Fig. 2 , addition of0.3% (vol/vol) of these high M r proteincontaining fractions to the culture medium did not result in an enhancement of colony growth. However, addition of 0.3% (vol/vol) of low Mr protein fractions 59 through 72, containing very low protein concentration ( < 1 -2 ~g/ml) supported the growth of both C F U -G M and BFU-E, with a maximal level of growth in fractions 62 and 69 containing 10-15-kD protein. These fractions were chosen for further purification by R P -H P L C technique. After HPLC separation of fraction 62, the enhancing activity for both G Mcolony growth and BFU-E growth was found in fractions 30-32 (Fig. 3) . Fraction 32 supported C F U -G M and BFU-E growth up to 75 + 12% and 125 + 20% of control cultures, respectively. The HPLC fractions, which contained the highest growth supportive activity, were electrophoretically analyzed for purity by means of SDS-PAGE, and the molecular mass was defined as shown in Fig. 4 . The HPLC fractions 30-32 from gel fihration fraction 62 showed a distinct protein band of 15 kD, with the highest concentration in fraction 32(g32). An automated protein sequencer was used to sequence the first 30 NH2R-terminal amino acid residues o f the protein, and they revealed complete structural identity with homology to the NH2-terminal sequence of the serine proteinase inhibitor ALP. ALP consists of a total of 107 residues. W h e n purified natural protein was digested with formic acid, sequence analysis of the internal amino acids 50 to 76 showed again identity to ALP, confirming its complete homology to ALP (Fig. 5) . Similarly, the second peak of activity from gel filtration (fractions 68 and 69) was purified by HPLC, yielding again a predominant 15-kD protein (fraction 28), which was also identified as ALP by NH2-tenmnal sequence analysis (45 residues) (Fig. 5) . As shown in Fig. 6 , purified rALP could also support the growth o f C F U -G M and B F U -E similar to 5637 C M or the purified 15-kD protein. Polyclonal anti-huALP antibodies could completely neutralize the biologic activity of 5637 C M (10% vol/vol), H P L C fraction-32 (0.1% vol/ vol), and rALP (10 ng/ml). However, the support of AB serum (1% vol/vol) on H P C growth could not be neutralized by polyclonal anti-huALP antibodies (Fig. 6) . l<e-placement of serum by the serine proteinase inhibitor c~-1 PI (2 Ixg/ml), present in serum at a concentration as high as 25 p,M, supported the growth o f both C F U -G M and BFU-E progenitors similar to rALP. c~-1 PI supported 69 ---20% of C F U -G M and 137 -+ 38% of B F U -E growth as compared to AB serum (n = 3). Replacement of rALP by its domains ALP-D-1 or ALP-D-2, separately or in combination at molar concentrations equivalent to rALP, showed that the C O O H -t e r m i n a l domain A L P -D -2 contained the active site (Fig. 7) .
Influence of Antileukoproteinase on the Suppressive Effect of Accessory Cells on HPC Growth in the Absence of Serum.
Monocyte-and T lymphocyte-depleted bone marrow cells were separated with Dynabeads into C D 3 4 -cells and a population containing 80% CD34 + cells. Fig. 8 shows the colony growth of these purified CD34 + cells in the absence or presence of increasing numbers of C D 3 4 -cells. In two separate experiments, it was shown that the inhibited growth of C F U -G M and BFU-E, induced by the C D 3 4 -accessory cells in the absence of serum, was completely reconshtuted by the addition of rALP (100 ng/ml) or C M (10% Figure 5 . Amino acid sequence analysis of HPC growth-supporting fractions (f) purified from 5637-cell CM. Amino acid sequences were determined by Edman degradation with an on-line Applied Biosystems 477A/120A sequencer. Since cysteine residues cannot be detected unless modified, their presence was deducted .from the absence of any detectable amino acid signal at such position. ALP sequence data are available from EMBL/GenBank/DDBJ under accession numbers P03973 and P07757. vol/vol). The proteinase inhibitor o~-1 PI (2 txg/ml), present in serum at concentrations of 1-2 Dg/ml, could also neutralize the suppression of both CFU-GM and BFU-E growth by CD34-cells in the absence of serum.
Discussion
In the presence of multiple HGF, insulin, cholesterol, and a highly purified clinical grade source of human albumin, we observed that in vitro HPC present in monocyteand T lymphocyte-depleted bone marrow failed to proliferate and differentiate into mature colonies of myeloid and erythroid cells. In contrast, purified CD34 + cells proliferated in the absence of human AB serum. Reconstitution experiments showed that accessory cells were responsible for suppression of growth of HPC in the absence of serum and that the addition of serum could restore HPC growth. This study, similar to studies presented by several other investigators (I-7), shows that in the presence of high concentrations of BSA, growth of HPC was observed almost similar to the numbers of colonies in the presence of serum (data not shown). Since BSA is usually <95-99% pure (8, 9) , unidentified serum factors bound to albumin may have influenced the results. Serum-free CM from the bladder carcmoma cell line 5637 could replace the need for serum or BSA in the senfisolid medium cultures to support the growth of HPC from normal bone marrow. Activity-based purification of this CM led to the isolation of a protein with a molecular mass of 15 kD (SDS-PAGE) that was identified by NH2R-terminal sequence analysis as ALP, a potent inhibitor of leukocyte elastase. The effect of this pu- rifled ALP on HPC growth could also be confirmed by rALP. Both purified natural and recombinant ALP supported 100% of erythroid colony growth and >60% of the myeloid colony growth as compared to the control culture in the presence of 10% AB serum. In addition, we could completely neutralize the biologic activity from 5637-CM and purified natural ALP with a polyclonal IgG antihuALP, illustrating that ALP was the factor essential for the in vitro HPC growth from monocyte-and T lymphocytedepleted bone marrow cells in the presence of highly purified human albumin. ALP is a 107-amino acid cationic protein consisting of two domains of similar architecture but with different inhibitory activities (18, 19) . The NH~-terminal domain ALP-D-1 that is assumed to bind trypsin could not support growth of HPC in the absence of serum. The COOH-temfinal domain ALP-D-2, containing a strong inhibitory activity against chymotrypsin, neutrophil elastase, and trypsin, restored the colony growth, indicating that the proteinase inhibitory activity of ALP was indeed responsible for the support of the HPC growth in vitro. ALP, also known as secretory leukocyte proteinase inhibitor, is present in a wide variety of mucous secretions and produced by epithelial-like cells (20) . This local production of ALP with very high affinity for leukocyte elastase serves as a potential regulatory feedback mechanism to prevent epithelial damage caused by proteolytic proteinases (21) . Regulatory effects of ALP in hematopoiesis have not been described previously. Serum contains various serine proteinase inhibitors, of which 0r PI and o~2-macroglobulin are present at relatively high concentrations of 1.3 mg/ml and 1.7 mg/ml, respectively (22) ; ALP has been found to circulate at a concentration of 5(i) ng/ml (21) . '201 _.,/%. CD34-/CD34+ ratio teinase inhibitor of neutrophil elastase (22) , the growth support was comparable to rALP. These results support the evidence that the proteinase inhibitory activity is responsible for the observed effects. The high concentrations of other serine proteinase inhibitors may explain why antihuALP antibo :lies did not abolish the stimulatory effect of serum.
Since the bone marrow accessory cells responsible for the suppression of growth of CD34-purified HPC were depleted of monocytes and T lymphocytes, the myeloid cells appeared to be the mediator cells for this effect. Probably, these myeloid cells secrete proteolytic proteinases like neutrophil elastase that are capable of degrading cytokines, growth factor receptors, or other proteins essential for the proliferation of HPC (23) (24) (25) . ALP or other proteinase inhibitors present in serum apparently neutralized these proteolytic enzymes. The mechanisms by which ALP supported the proliferation of HPC in vitro may be at the cell membrane level by protecting from degradation cellular receptors or proteins in the culture medium that are essential for HPC growth. In conclusion, we demonstrated that monocyte-and T lymphocyte-depleted accessory bone marrow cells suppressed the in vitro growth o f C D 3 4 + HPC in the absence of serum. The serine proteinase inhibitor ALP was capable of restoring the proliferation of H P C in vitro in the presence of multiple HGF, highly purified albumin, insulin, and cholesterol. These results show that proteinase inhibitors are important for optimal in vitro growth of HPC and may be essential for in vitro expansion of human hematopoietic stem cells in serum-free medium.
